RU2230534C1 - Device for adjusting functional human organism systems - Google Patents

Abstract

FIELD: medical engineering.

SUBSTANCE: device has spectacles having two light-insulated oculars each having light-scattering reflector. Light emission source is rigidly mounted in reflector as a set of photodiode emitters of various light radiation wavelengths. The device has master oscillator, flicker frequency control unit and power supply source, light radiation brightness control unit, in series connected control unit, modulating impulse former and modulator, two commutation units. Lightproof screen having 5-8 openings of 1.5-3.5 mm diameter are available in each light-scattering reflector in front of light radiation source.

EFFECT: enhanced effectiveness of treatment; accelerated treatment course.

4 dwg

Description

The invention relates to medicine, and more particularly to a device for correcting the functional systems of the human body, in particular for improving visual functions.

The invention can be used to correct visual, central nervous, immune, endocrine, cardiovascular and other body systems. In particular, the invention can be used for the treatment and prevention of various pathologies of the organ of vision, including glaucoma, cataracts, pathology of the retina and optic nerve, for vision correction in congenital weak vision, inability to correct with glasses, myopia, hyperopia, presbyopia, strabismus.

A device for correcting the functional systems of the human body (patent No. 2098059, class A 61 F 9/00, 1997) is known, which contains glasses with two light-insulated eyepieces, each of which has a light-scattering reflector, inside of which a source of LED radiation is rigidly fixed. At the same time, the device has a master oscillator, a power supply, a regulator of brightness and pulse frequency of light emission.

However, the light-scattering reflector in the light-insulated eyepieces does not provide a response of visual neurons, which are important for their activation when the entire retina is illuminated with diffuse (scattered) light, which causes the mutual excitation of the exciting and inhibitory zones of the receptive fields of the visual neurons - the phenomenon of antagonism. In this regard, this device does not give the desired effect, and the treatment time is extended, especially with color therapy of advanced stages of the disease.

The technical result of the invention is to increase efficiency and reduce treatment time.

The technical result is achieved by the fact that the device for correcting the functional systems of the human body contains glasses with two light-insulated eyepieces, each of which has a light-scattering reflector, inside of which a light radiation source is rigidly fixed in the form of a set of LED emitters of different wavelengths of light radiation. The device comprises a master oscillator, a controller for blinking light frequency and a power supply unit, a brightness controller for light radiation, a control unit, a modulating pulse shaper and a modulator connected in series, the inputs of which are connected respectively to the outputs of the controller for blinking light frequencies, and the outputs to corresponding inputs of a brightness controller light radiation, two switches, each of which is connected with its input to the light radiation radiation regulator, and with an output - to the source Vetovo emission control unit outputs are connected to the control inputs of the frequency controller blinking light emission, light emission luminance controller and switch; in each light-scattering reflector opposite the light source there is a light-tight screen with 5-8 holes with a diameter of 1.5-3.5 mm.

Figure 1 schematically shows a device for correcting the functional systems of the human body, made according to the invention, a top view; figure 2 is an electronic circuit of a device made according to the invention; figure 3 - panel control point of a device made according to the invention; figure 4 is a lightproof screen.

A device for correcting the functional systems of the human body contains glasses (Fig. 1) with two light-insulated eyepieces. Each eyepiece has a light-scattering reflector 1, inside which a light-tight screen 2 is installed, LED emitters 3, 4 of different wavelengths are fixed against it: from 400 to 700 nm. Figure 4 shows a lightproof screen with 5 holes. The holes can be from 5 to 8, while their diameter is from 1.5 to 3.5 mm. The device includes a master oscillator 5 (figure 2), a regulator 6 of the blinking frequency of the light radiation, forming two antiphase pulse sequences in the frequency range from 0.06 to 1 Hz, a regulator 7 of the brightness of light radiation, two switches 8, 9, each which provides a given light effect on the corresponding eye, and a control unit 10, a shaper 11 of modulating pulses with a frequency of 2 to 64 Hz and a modulator 12 are connected in series.

The master oscillator 5 is connected to the input 13 of the controller 6 of the blinking frequency of the light radiation having two outputs connected to the corresponding inputs 14, 15 of the modulator 12, the two outputs of which are connected to the corresponding inputs 16, 17 of the controller 7 of the brightness of the light radiation, connected by its outputs to the input 18 , 19 of the corresponding switch 8, 9. The control unit 10 with its outputs is connected to the input 20 of the controller 6 of the blinking light frequency, input 21 of the controller 7 of the brightness of light radiation, inputs 22, 23 of each switch 8, 9 and ode 24 modulating pulse generator 11, whose output is connected to the input 25 of the modulator 12. The output of each switch 9 is connected to the LED emitters 3, 4 of the corresponding eyepiece.

In this case, the device has a remote control 26 (Fig. 3) for control and monitoring, connected by its input to the power supply. Moreover, in the case of using industrial frequency voltage, a power supply is used, which is an adapter 27, which converts this voltage to a voltage of 9-12 V, safe for the user. The control and control panel 26 has a transparent window 28 with indicator LEDs installed therein corresponding to LED emitters of 8, 9 colors, which allow controlling the wavelength of light radiation, pseudo-sensor switches 6 ¹ , 7 ¹ , 8 ¹ , 9 ¹ , 11 ¹ , 12 ¹ for setting various modes of light radiation and adjusting its brightness, a timer 29, which ensures that the entire device is turned off after a predetermined time and a connector 30 to which glasses 1 are connected.

The device operates as follows.

The patient wears glasses, in the eyepieces of which a set of LED emitters 3 of different wavelengths from 400 to 700 nm are installed inside the light-scattering reflectors 1. When voltage is applied to the input of the device, the light-emitting frequency control unit 6 generates two antiphase pulse sequences in the frequency range from 0.06 to 1 Hz, which are fed to the inputs 14, 15 of the modulator 12, the pulse train generator 11 generates a pulse sequence (meander) with a frequency of 2 to 64 Hz, which modulates in the modulator 12 the amplitude of the signals of the controller 6 of the blinking frequency of the light radiation. The modulated signals are regulated in amplitude in the dimmer 7 and are fed through switches 8, 9 to LED emitters 3, 4 of the corresponding wavelength located in the eyepieces. Using the switches 8 and 9 set the desired color for each of the eyes. By means of the regulator 6 of the blinking frequency of the light radiation, the blinking frequency of the light radiation is set in the range from 0.06 to 1 Hz. Adjustment of the level of output radiation is carried out by means of the regulator 7 of the brightness of the light radiation stepwise through 1.5 dB (4 positions). In this case, the maximum brightness of the radiation is from 1.5 mW (for red) to 0.05 mW (for other colors). By means of a shaper 11 modulating pulses include pulse modulation of rhythms with a frequency of 8, 16 or 32 Hz. Set the operation mode of the device depending on the pathology. The electronic circuit allows the formation of the following radiation modes:

- alternating effects on the eyes with a period of 4-8 s;

- periodic exposure to one of the eyes and continuous exposure to the other;

- any of the above modes with modulation of the radiation meander with a frequency of 8, 16 or 32 Hz.

In this case, you can affect both eyes with the same or different wavelengths:

- 660 nm (red color);

- 600 nm (orange color);

- 567 nm (green color);

- 470 nm (blue color).

Timer 29 ensures that the device turns off after a certain time (for example, 8.5 minutes).

During the operation of the above scheme, pulsed light emission from the LEDs 3, 4 occurs in the light-scattering reflector 1. Light passes through the openings of the opaque screen, as a result of which the patient observes the pulsation of the light stimuli.

The presence of radiation brightness control allows you to quickly set the brightness of the LED emitters individually for each of the patients.

To set various modes of light radiation and adjust its brightness, pseudo-sensor push buttons 6 ¹ , 7 ¹ , 8 ¹ , 9 ¹ , 11 ¹ , 12 ^{1 are used} . The radiation wavelength is controlled by indicator LEDs located in a transparent window 28 of the control and monitoring panel 26 of the device.

The presence of a screen with small openings provides a response of the visual neurons of the retina of the eye and brain due to stimulation or the exciting or inhibitory zone of the receptive fields of the visual neurons, i.e. the mechanism of the phenomenon of antagonism. As a result, the visual function and the function of the regulatory structures of the brain (hypothalamus, pituitary, etc.) increase, which increases the effectiveness of treatment and shortens the treatment time.

The device has small dimensions, which allows it to be used both in specialized clinics and at home. The power consumption is not more than 40 mW, and the mass (without glasses and a network adapter) does not exceed 200 g.

The device is illustrated by the following examples.

Example 1

Patient I., 47 years old. Diagnosis: presbyopia. Complaints of decreased vision during visual work near. Before treatment: visual acuity of the right eye of 0.9; left eye 1.0. According to the table near, he reads the font without correction with his right eye No. 7 (visual acuity 0.4), with his left eye - No. 5 (visual acuity 0.6).

After one session of color therapy using the proposed device according to the table for near, he reads font No. 5 without correction with his right eye and No. 2 with his left eye (visual acuity 0.6 and 0.9, respectively). Therefore, this patient does not need glasses for close-range visual work.

Example 2

Patient T., 46 years old. Complaints of decreased vision during visual work near. Diagnosis: presbyopia. Visual acuity of the right eye of 0.9, the left eye of 1.0. According to the table for near, he reads font No. 6 without correction with his right eye, and No. 7 with his left eye.

After color therapy, carried out for 5 days using the proposed device, according to the table for near reads font No. 2 without correction (visual acuity = 0.9).

Example 3

Patient K., 56 years old. Complaints of decreased vision both in the distance and near. Diagnosis: presbyopia, hyperopia of a weak degree in both eyes. Before treatment: visual acuity of the right eye of 0.2, spheres. +1.0 D = 1.0; left eye 0.1, spheres. +1.5 D = 1.0. According to the table for near without correction distinguishes font No. 10 with the right and left eye (visual acuity = 0.1). With the correction of spheres +2.5 D, corresponding to the age of the patient, he reads the font No. 8 (visual acuity 0.3).

After 3 sessions of color therapy using the proposed device, visual acuity into the distance without correction of the right eye = 0.7, left eye = 0.5, binocular = 0.8. After the 5th session, 1.0 and 0.6, respectively. According to the table for near without correction the right and left eye reads font No. 4, which corresponds to visual acuity near 0.7. Therefore, after the treatment, the patient does not need corrective glasses for both distance vision and close visual work.

All patients with presbyopia (45 people) in the process of color retinal stimulation through an opaque screen placed on a light-scattering reflector in glasses observed pulsation of light stimuli corresponding to the screen openings, which testified to the response of visual neurons of the retina of the eye and brain to color stimuli.

Thus, the present invention provides increased function of the visual neurons of the retina and brain, which significantly reduces the treatment time and is an effective method for correcting presbyopia without optical lenses, as well as preventing its progression.

The effect of retinal color stimulation using the proposed device on visual functions in case of myopia, hyperopia of refractive amblyopia, initial cataract, glaucoma, retinal and optic nerve pathology and the general condition of patients with concomitant diseases (hypertension, neurasthenic syndrome, central nervous system dysfunction, endocrine, and other digestive organs, was studied). systems).

Example 4

Patient M., 34 years old., Diagnosis: refractive amblyopia, complex myopic astigmatism in both eyes. Before treatment: visual acuity of the right and left eye = 0.06, with correction = 0.5. After a course of treatment for 8 days using the proposed device, the visual acuity of the right and left eye is 0.3 with a correction of 0.8. Therefore, despite the patient's age (34 years), high visual acuity was achieved with refractive amblyopia of both eyes.

Example 5

Patient R., 13 years old. Diagnosis: progressive myopia of moderate degree. Before treatment, visual acuity of the right and left eye = 0.06, with correction of the spheres. -4.0 D = 1.0. After a course of treatment for 10 days, respectively, 0.08, with correction of the spheres. -2.5 D = 1.0. A decrease in optical correction by 1.5 D in this patient indicates that the proposed device provides prevention of the progression of myopia and a decrease in the strength of corrective glasses.

Example 6

Patient 3., 47 years old. Diagnosis: mild myopia. Before treatment, visual acuity of the right and left eye = 0.1, with correction of the spheres. -2.5 D = 1.0; after a course of treatment using the proposed device, the visual acuity of the right eye of 0.8, the left eye of 0.5, with correction of the spheres. -1.0 D = 1.0, this patient achieved a significant increase in visual acuity without correction and, therefore, there was no need for constant wearing of corrective glasses.

Example 7

Patient D., 67 years old. Diagnosis: initial cataract of the right eye, artifact and subluxation of the intraocular lens of the left eye.

Before treatment: visual acuity of the right eye 0.1, spheres. +3.0 D = 0.5; left eye 0.01, spheres. +11.0 D = 0.2.

After color retinal stimulation using the proposed device, the visual acuity of the right eye of 0.2 spheres. +3.0 D = 1.0; left eye with correction of spheres. +10.0 D = 0.3.

Thus, the normalization of visual acuity in the right eye indicates that the present invention provides for the prevention of cataract progression in the initial stage and the normalization of visual acuity. In addition, it prevents the psycho-emotional stressful experiences that occurred before color therapy in this patient in connection with the upcoming surgery on the best eye and underwent an unsuccessful operation on the left eye.

Example 8

Patient M., 6 years old. Diagnosis: congenital atrophy of the optic nerve, medium-sightedness of moderate degree in both eyes, convergent strabismus, dysbinocular amblyopia of a very high degree and nystagmus of the left eye. From birth, the child is monitored and treated by a neurologist and optometrist.

Before treatment: visual acuity of the right eye of 0.2 spheres. +3.0 D = 0.4; left eye 0.01, visual fixation is absent. The angle of deviation of the left eye to the nose is from 30 to 50 °.

After color stimulation using the proposed device for 15 days, the visual acuity of the right eye is 1.0 without correction; of the left eye with a correction of 0.08 with an eccentric unstable fixation, nystagmus is insignificant, the strabismus angle decreased to 10-20 °.

Thus, the child achieved normalization of visual acuity of the right eye, improved vision of the left eye and a significant reduction in the angle of strabismus.

Example 9

Patient L., 12 years old. Diagnosis: congenital partial atrophy of the optic nerve of the right eye, complete atrophy of the optic nerve and convergent squint of the left eye, congenital cerebral palsy, right-sided hemiparesis.

The girl is constantly being treated by an optometrist and a neurologist.

Before treatment: visual acuity of the right eye of 0.3, spheres. +1.0 D = 0.5; left eye - 0 (zero). The angle of deviation to the nose is 10 °.

After treatment with the proposed device, the visual acuity of the right eye is -0.5, spheres. -1.0 D = 1.0; left eye = 0. Strabismus = 0 °.

Thus, the proposed device provides high efficiency in congenital gross pathology of the optic nerve, as evidenced by the normalization of visual acuity in the best eye, the disappearance or significant reduction of strabismus.

Example 10

Patient D., 67 years old. Diagnosis: initial cataract of both eyes. Concomitant diseases: coronary heart disease, angina pectoris, VVD, cephalgia, gastrointestinal tract dysfunction, common osteochondrosis.

Before treatment: visual acuity of the right and left eye 0.7, the glasses are not corrected. After color stimulation using the proposed device for 7 days, the visual acuity of the right and left eyes returned to normal and amounted to 1.0. Along with the improvement of visual functions, the patient's general condition also improved: headaches and pains in the spine disappeared, gastrointestinal function improved, and working capacity improved.

Example 11

Patient A., 24 years old. Diagnosis: high degree hyperopia of both eyes. Before treatment, visual acuity of the right eye of 0.7, the left eye of 0.3. spheres. +1.5 D = 0.9 and 0.7, respectively. Refraction of both eyes with hypermetropia of 6.0 D. After color stimulation using the proposed device, visual acuity without correction of the right eye = 1.0; left eye = 0.8. The refraction of both eyes decreased and was equal to hyperopia of 4.0 D.

Thus, the normalization of visual acuity and a decrease in the degree of hyperopia were achieved in this patient.

Example 12

Patient Sh., 64 years old. Diagnosis: diabetic retinopathy, condition after laser coagulation of the retina of both eyes, initial cataract, diabetes mellitus. Before treatment: visual acuity of the right eye 0.1, left eye 0.4, with correction of the spheres. +1.0 D = 0.2 and 0.6, respectively. Blood sugar 7.3-7.8 mmol / l during treatment with antidiabetic drugs. After color stimulation using the proposed device, the visual acuity of the right eye of 0.3, is not corrected, the left eye of 0.7, spheres. +1.0 D = 1.0. Blood sugar content is 5.4-5.8 mmol / L. The general condition of the patient has improved significantly.

Thus, a significant positive effect was achieved with the difficult to treat complication of diabetes mellitus - diabetic retinopathy. At the same time, the blood sugar level returned to normal.

Example 13

Patient L., 64 years old. Diagnosis: macular degeneration of both eyes: wet form on the right and dry form on the left eye, initial cataract of both eyes. A year ago, retinal laser coagulation of both eyes was performed and medication is periodically performed.

Before treatment: visual acuity of the right eye 0.1; left eye 0.1; with correction of spheres. +2.5 D = 0.3 and 0.5. After color stimulation using the proposed device, the visual acuity of the right eye of 0.5; left eye 0.7, with correction of the spheres. +2.5 D = 1.0 in both eyes.

Thus, the achieved high visual acuity with almost unacceptable conventional drug and laser treatment of such a retinal pathology as macular degeneration indicates that the proposed device is highly effective both in improving visual functions and in preventing blindness in this disease.

Claims (1)

A device for correcting the functional systems of the human body, containing glasses with two light-insulated eyepieces, each of which has a light-scattering reflector, inside of which a light radiation source is rigidly fixed in the form of a set of LED emitters of different wavelengths of light radiation, while the device has a master oscillator, a blinking frequency controller light emission and a power supply unit, a regulator of brightness of light radiation, a control unit connected in series, a shaper modulating x pulses and a modulator, the inputs of which are connected respectively to the outputs of the regulator of the blinking frequency of light radiation, and the outputs are connected to the corresponding inputs of the brightness control of light radiation, two switches, each of which is connected with its input to the brightness control of light radiation, and the output is connected to a light source , the outputs of the control unit are connected to the control inputs of the controller of the blinking frequency of the light radiation, the brightness control of the light radiation and the switches, characterized in that in each light a diffusing reflector opposite the light radiation source has a lightproof screen with 5-8 holes with a diameter of 1.5-3.5 mm.

Images